Literature DB >> 3819731

Phenylalanine transport across the blood-brain barrier as studied with the in situ brain perfusion technique.

S Momma, M Aoyagi, S I Rapoport, Q R Smith.   

Abstract

Unidirectional L-phenylalanine transport into six brain regions of pentobarbital-anesthetized rats was studied using the in situ brain perfusion technique. This technique allows both accurate measurements of cerebrovascular amino acid transport and complete control of perfusate amino acid composition. L-Phenylalanine influx into the brain was sodium independent and could be described by a model with a saturable and a nonsaturable component. Best-fit values for the kinetic constants in the parietal cortex equaled 6.9 X 10(-4) mumol/s/g for Vmax, 0.011 mumol/ml for Km, and 1.8 X 10(-4) ml/s/g for KD during perfusion with fluid that did not contain competing amino acids. D-Phenylalanine competitively inhibited L-phenylalanine transport with a Ki approximately 10-fold greater than the Km for L-phenylalanine. There were no significant regional differences in Km, KD, or Ki, whereas Vmax was significantly greater in the cortical lobes than in the other brain regions. L-Phenylalanine influx during plasma perfusion was only 30% of that predicted in the absence of competing amino acids. Competitive inhibition increased the apparent Km during plasma perfusion by approximately 20-fold, to 0.21 mumol/ml. These data provide accurate new estimates of the kinetic constants that describe L-phenylalanine transport across the blood-brain barrier. In addition, they indicate that the cerebrovascular transfer site affinity (1/Km) for L-phenylalanine is three- to 12-fold greater than previously estimated in either awake or anesthetized animals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3819731     DOI: 10.1111/j.1471-4159.1987.tb05660.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.

Authors:  Paul R Lockman; Joanna Koziara; Karen E Roder; Jennifer Paulson; Thomas J Abbruscato; Russell J Mumper; David D Allen
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

Review 2.  Transport of amino acids across the blood-brain barrier: implications for treatment of maternal phenylketonuria.

Authors:  R M Gardiner
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model.

Authors:  Claude Dagenais; Alex Avdeef; Oksana Tsinman; Adam Dudley; Richard Beliveau
Journal:  Eur J Pharm Sci       Date:  2009-07-08       Impact factor: 4.384

4.  Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer.

Authors:  Fancy C Thomas; Kunal Taskar; Vinay Rudraraju; Satyanarayana Goda; Helen R Thorsheim; Julie A Gaasch; Rajendar K Mittapalli; Diane Palmieri; Patricia S Steeg; Paul R Lockman; Quentin R Smith
Journal:  Pharm Res       Date:  2009-09-23       Impact factor: 4.200

5.  Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.

Authors:  Werner J Geldenhuys; Vamshi K Manda; Rajendar K Mittapalli; Cornelis J Van der Schyf; Peter A Crooks; Linda P Dwoskin; David D Allen; Paul R Lockman
Journal:  Bioorg Med Chem Lett       Date:  2009-12-28       Impact factor: 2.823

Review 6.  11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Authors:  Tarun Singhal; Tanjore K Narayanan; Viney Jain; Jogeshwar Mukherjee; Joseph Mantil
Journal:  Mol Imaging Biol       Date:  2007-10-24       Impact factor: 3.488

7.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.

Authors:  Y Takada; N H Greig; D T Vistica; S I Rapoport; Q R Smith
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

9.  Effect of aging on the kinetics of blood-brain barrier uptake of tryptophan in rats.

Authors:  J P Tang; S Melethil
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

10.  Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides.

Authors:  E G Chikhale; K Y Ng; P S Burton; R T Borchardt
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.